ArticleBMC cardiovascular disorders2025
Changes in the estimated glucose disposal rate and incident cardiovascular disease in patients with cardiovascular-kidney-metabolic syndrome stages 0-3: a prospective cohort study in China.
Article in BMC cardiovascular disorders, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Cardiovascular-kidney-metabolic syndrome: a comprehensive review of pathophysiology, epidemiology, diagnosis, and management.Cardiovascular diabetology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BACKGROUND AND
aimsCardiovascular-kidney-metabolic syndrome (CKM) significantly increases the burden of cardiovascular disease (CVD), particularly in China, which has a rapidly aging population. The estimated glucose disposal rate (eGDR) is a reliable indicator for assessing insulin resistance (IR), but its dynamic changes and association with the risk of new-onset CVD in patients with CKM syndrome have not been fully elucidated. The aim of this study was to investigate the associations between dynamic changes in and cumulative of eGDR (cumeGDR) and the risk of new-onset CVD in Chinese adults with CKM syndrome.
methodsA total of 2862 patients with CKM syndrome stages 0-3 without CVD at baseline from the China Health and Retirement Longitudinal Study (CHARLS) were enrolled. K-means clustering was used to measure the change in eGDR from 2012 to 2015, and the cumulative eGDR level was calculated. Logistic regression, restricted cubic splines (RCS), and subgroup analysis were used to explore the potential associations between changes in the eGDR and the risk of new-onset CVD (including heart disease and stroke) in patients with CKM syndrome stages 0-3.
resultsDuring the 3-year follow-up period, 404 (14.1%) CVD events occurred, including 254 heart disease cases and 177 stroke cases. After adjusting for confounding factors, compared with the group with persistently high eGDR level (Class 1), the groups with significantly decreased eGDR level (Class 2) and persistently low eGDR level (Class 3) had a significantly increased CVD risk (Class 2: OR = 1.82 [1.36-2.45], P < 0.001;Class 3: OR = 1.90 [1.41-2.56], P < 0.001). Further RCS regression analysis revealed a negative linear association between the cumulative eGDR and CVD risk(P for overall < 0.001, nonlinear P = 0.922).
conclusionPersistently low eGDR level are associated with an increased risk of new-onset CVD in those with CKM syndrome stages 0-3. Continuous dynamic monitoring of the eGDR may help identify high-risk individuals with CKM syndrome stages 0-3 and provide critical evidence for early intervention.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.